ROIV logo

Roivant Sciences (ROIV) Company Overview

Profile

Full Name:

Roivant Sciences Ltd.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United Kingdom

IPO:

December 8, 2020

Indexes:

Not included

Description:

Roivant Sciences is a biopharmaceutical company focused on developing innovative medicines. They create and manage "Vants," which are specialized companies that work on specific diseases. Roivant aims to speed up the drug development process and bring new treatments to patients more quickly.

Key Details

Price

$10.30

Annual Revenue

$124.80 M(+103.65% YoY)

Annual EPS

$5.23(+468.31% YoY)

Annual ROE

107.97%

Beta

1.02

Events Calendar

Earnings

Next earnings date:

May 30, 2025

Recent quarterly earnings:

Feb 10, 2025

Recent annual earnings:

May 30, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 11, 25 HC Wainwright & Co.
Buy
Nov 13, 24 HC Wainwright & Co.
Buy
Sep 19, 24 HC Wainwright & Co.
Buy
Sep 19, 24 Cantor Fitzgerald
Overweight
Sep 11, 24 HC Wainwright & Co.
Buy
Sep 11, 24 B of A Securities
Neutral
Sep 9, 24 Cantor Fitzgerald
Overweight
Aug 19, 24 HC Wainwright & Co.
Buy
Jul 10, 24 Piper Sandler
Overweight
Jun 18, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Roivant Sciences?
  • Does Roivant Sciences pay dividends?
  • What sector is Roivant Sciences in?
  • What industry is Roivant Sciences in?
  • What country is Roivant Sciences based in?
  • When did Roivant Sciences go public?
  • Is Roivant Sciences in the S&P 500?
  • Is Roivant Sciences in the NASDAQ 100?
  • Is Roivant Sciences in the Dow Jones?
  • When was Roivant Sciences's last earnings report?
  • When does Roivant Sciences report earnings?
  • Should I buy Roivant Sciences stock now?

What is the ticker symbol for Roivant Sciences?

The ticker symbol for Roivant Sciences is NASDAQ:ROIV

Does Roivant Sciences pay dividends?

No, Roivant Sciences does not pay dividends

What sector is Roivant Sciences in?

Roivant Sciences is in the Healthcare sector

What industry is Roivant Sciences in?

Roivant Sciences is in the Biotechnology industry

What country is Roivant Sciences based in?

Roivant Sciences is headquartered in United Kingdom

When did Roivant Sciences go public?

Roivant Sciences's initial public offering (IPO) was on December 8, 2020

Is Roivant Sciences in the S&P 500?

No, Roivant Sciences is not included in the S&P 500 index

Is Roivant Sciences in the NASDAQ 100?

No, Roivant Sciences is not included in the NASDAQ 100 index

Is Roivant Sciences in the Dow Jones?

No, Roivant Sciences is not included in the Dow Jones index

When was Roivant Sciences's last earnings report?

Roivant Sciences's most recent earnings report was on Feb 10, 2025

When does Roivant Sciences report earnings?

The next expected earnings date for Roivant Sciences is May 30, 2025

Should I buy Roivant Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions